Microsoft, Google back DNAnexus’ Big Data work with $58M; Novartis, Temasek back $50M round for Pear’s med apps

(Source: Endpoints News) You can also expect an advisory committee hearing on the application. → The penny stock biotech Protalix $PLX ran out a positive, early stage snapshot of the data they’re seeing in a mid-stage study of OPRX-106 (oral anti-TNF) in patients with ulcerative colitis. Researchers for the Israeli company touted a 36% remission …